iANTHUS CAPITAL HOLDINGS (ITHUF) Cash & Equivalents (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Cash & Equivalents came in at $11.1 million in Q1 2026, down 54.06% year-on-year from $24.2 million in Q1 2025, and down 4.41% quarter-over-quarter from $11.6 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Cash & Equivalents (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Cash & Equivalents across 6 years of filings, most recently posting $11.1 million for Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $11.1 million, down 54.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.1 million (down 54.06% YoY), and the FY2025 annual result was $11.6 million, down 37.17% from the prior year.
- Cash & Equivalents came in at $11.1 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $11.6 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $24.2 million in Q1 2025 to a low of $679000.0 in Q4 2023.
- The 4-year median for Cash & Equivalents is $15.1 million (2023), against an average of $15.0 million.
- Across the five-year window, Cash & Equivalents jumped 2630.93% in 2024 and slumped 54.06% in 2026, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Cash & Equivalents stood at $679000.0 in 2023, then surged by 2630.93% to $18.5 million in 2024, then slumped by 37.17% to $11.6 million in 2025, then declined by 4.41% to $11.1 million in 2026.
- The last three Cash & Equivalents figures came in at $11.1 million (Q1 2026), $11.6 million (Q4 2025), and $17.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 266.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 47.17 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 222.79 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 11.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.14 Mn |
| Dec 31, 2025 | 11.65 Mn |
| Sep 30, 2025 | 17.21 Mn |
| Jun 30, 2025 | 23.46 Mn |
| Mar 31, 2025 | 24.24 Mn |
| Dec 31, 2024 | 18.54 Mn |
| Sep 30, 2024 | 19.94 Mn |
| Jun 30, 2024 | 16.55 Mn |
| Mar 31, 2024 | 13.62 Mn |
| Dec 31, 2023 | 679,000.00 |
| Sep 30, 2023 | 15.10 Mn |
| Jun 30, 2023 | 10.07 Mn |
| Mar 31, 2023 | 12.30 Mn |
| Dec 31, 2021 | 568,000.00 |
| Dec 31, 2020 | 512,000.00 |